Pursuant to Regulation 47 of SEBI (LODR) 2015, please find enclosed copies of the newspaper advertisement published in India Express (English) and Financial Express (Gujarati) for the Extract ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed the stock exchanges that it has published extracts of its Unaudited Standalone and Consolidated Financial Results for the quarter ended September 30, 2025 in two newspapers — Indian Express (English) and Financial Express (Gujarati), as required under SEBI Listing Regulations. The filing is dated November 13, 2025 and is signed by Managing Director Jayendra Mehta. This is a routine regulatory disclosure to confirm that the quarterly results have been publicly disseminated via newspaper advertisements. No new financial numbers or business updates are disclosed in this particular filing — the actual results would have been filed separately.
This is a routine compliance filing and is unlikely to have any material impact on the stock price. Shareholders should look for the separately filed detailed Q2 FY26 financial results for any meaningful performance updates.